90 related articles for article (PubMed ID: 21737648)
41. Prognostic value of carcinoembryonic antigen and vascular endothelial growth factor tumor tissue content in colorectal cancer.
Ferroni P; Palmirotta R; Spila A; Martini F; Formica V; Portarena I; Del Monte G; Buonomo O; Roselli M; Guadagni F
Oncology; 2006; 71(3-4):176-84. PubMed ID: 17652942
[TBL] [Abstract][Full Text] [Related]
42. SCRN1 is a novel marker for prognosis in colorectal cancer.
Miyoshi N; Ishii H; Mimori K; Sekimoto M; Doki Y; Mori M
J Surg Oncol; 2010 Feb; 101(2):156-9. PubMed ID: 20039278
[TBL] [Abstract][Full Text] [Related]
43. High expression of PRL-3 promotes cancer cell motility and liver metastasis in human colorectal cancer: a predictive molecular marker of metachronous liver and lung metastases.
Kato H; Semba S; Miskad UA; Seo Y; Kasuga M; Yokozaki H
Clin Cancer Res; 2004 Nov; 10(21):7318-28. PubMed ID: 15534108
[TBL] [Abstract][Full Text] [Related]
44. Notch2 expression is decreased in colorectal cancer and related to tumor differentiation status.
Chu D; Zheng J; Wang W; Zhao Q; Li Y; Li J; Xie H; Zhang H; Dong G; Xu C; Li M; Chen D; Ji G
Ann Surg Oncol; 2009 Dec; 16(12):3259-66. PubMed ID: 19653042
[TBL] [Abstract][Full Text] [Related]
45. Clinicopathological significance of the gene expression of matrix metalloproteinase-7, insulin-like growth factor-1, insulin-like growth factor-2 and insulin-like growth factor-1 receptor in patients with colorectal cancer: insulin-like growth factor-1 receptor gene expression is a useful predictor of liver metastasis from colorectal cancer.
Oshima T; Akaike M; Yoshihara K; Shiozawa M; Yamamoto N; Sato T; Yamada R; Fujii S; Rino Y; Kunisaki C; Tanaka K; Masuda M; Imada T
Oncol Rep; 2008 Aug; 20(2):359-64. PubMed ID: 18636198
[TBL] [Abstract][Full Text] [Related]
46. Clinical significance of mitochondrial transcription factor A expression in patients with colorectal cancer.
Nakayama Y; Yamauchi M; Minagawa N; Torigoe T; Izumi H; Kohno K; Yamaguchi K
Oncol Rep; 2012 May; 27(5):1325-30. PubMed ID: 22266811
[TBL] [Abstract][Full Text] [Related]
47. MiR-429 is an independent prognostic factor in colorectal cancer and exerts its anti-apoptotic function by targeting SOX2.
Li J; Du L; Yang Y; Wang C; Liu H; Wang L; Zhang X; Li W; Zheng G; Dong Z
Cancer Lett; 2013 Feb; 329(1):84-90. PubMed ID: 23111103
[TBL] [Abstract][Full Text] [Related]
48. Prognostic value of regulator of G-protein signaling 6 in colorectal cancer.
Luo Y; Qin SL; Yu MH; Mu YF; Wang ZS; Zhong M
Biomed Pharmacother; 2015 Dec; 76():147-52. PubMed ID: 26653562
[TBL] [Abstract][Full Text] [Related]
49. Prognostic relevance of BRD7 expression in colorectal carcinoma.
Wu WJ; Hu KS; Chen DL; Zeng ZL; Luo HY; Wang F; Wang DS; Wang ZQ; He F; Xu RH
Eur J Clin Invest; 2013 Feb; 43(2):131-40. PubMed ID: 23215825
[TBL] [Abstract][Full Text] [Related]
50. Tumor-suppressive role of Kruppel-like factor 4 (KLF-4) in colorectal cancer.
Xiu DH; Chen Y; Liu L; Yang HS; Liu GF
Genet Mol Res; 2017 Feb; 16(1):. PubMed ID: 28218782
[TBL] [Abstract][Full Text] [Related]
51. Down-regulation of Barx2 predicts poor survival in colorectal cancer.
Mi Y; Zhao S; Zhang W; Zhang D; Weng J; Huang K; Sun H; Tang H; Zhang X; Sun X; Peng Z; Wen Y
Biochem Biophys Res Commun; 2016 Sep; 478(1):67-73. PubMed ID: 27453340
[TBL] [Abstract][Full Text] [Related]
52. Cell division cycle-associated protein 1 overexpression is essential for the malignant potential of colorectal cancers.
Kobayashi Y; Takano A; Miyagi Y; Tsuchiya E; Sonoda H; Shimizu T; Okabe H; Tani T; Fujiyama Y; Daigo Y
Int J Oncol; 2014 Jan; 44(1):69-77. PubMed ID: 24247253
[TBL] [Abstract][Full Text] [Related]
53. Prognostic role of serum AZGP1, PEDF and PRDX2 in colorectal cancer patients.
Ji D; Li M; Zhan T; Yao Y; Shen J; Tian H; Zhang Z; Gu J
Carcinogenesis; 2013 Jun; 34(6):1265-72. PubMed ID: 23393224
[TBL] [Abstract][Full Text] [Related]
54. Upregulation of WEE1 is a potential prognostic biomarker for patients with colorectal cancer.
Ge XC; Wu F; Li WT; Zhu XJ; Liu JW; Wang BL
Oncol Lett; 2017 Jun; 13(6):4341-4348. PubMed ID: 28599436
[TBL] [Abstract][Full Text] [Related]
55. Novel prognostic biomarkers in colorectal cancer.
Malesci A; Laghi L
Dig Dis; 2012; 30(3):296-303. PubMed ID: 22722555
[TBL] [Abstract][Full Text] [Related]
56. The relationship between TESTIN expression and the prognosis of colorectal cancer.
Zhu Y; Qiao Q
Pathol Res Pract; 2022 Apr; 232():153744. PubMed ID: 35219152
[TBL] [Abstract][Full Text] [Related]
57. VAV3 oncogene expression in colorectal cancer: clinical aspects and functional characterization.
Uen YH; Fang CL; Hseu YC; Shen PC; Yang HL; Wen KS; Hung ST; Wang LH; Lin KY
Sci Rep; 2015 Mar; 5():9360. PubMed ID: 25791293
[TBL] [Abstract][Full Text] [Related]
58. Phosphoserine Phosphatase Is a Novel Prognostic Biomarker on Chromosome 7 in Colorectal Cancer.
Sato K; Masuda T; Hu Q; Tobo T; Kidogami S; Ogawa Y; Saito T; Nambara S; Komatsu H; Hirata H; Sakimura S; Uchi R; Hayashi N; Iguchi T; Eguchi H; Ito S; Nakagawa T; Mimori K
Anticancer Res; 2017 May; 37(5):2365-2371. PubMed ID: 28476802
[TBL] [Abstract][Full Text] [Related]
59. Mitochondrial UQCRB as a new molecular prognostic biomarker of human colorectal cancer.
Kim HC; Chang J; Lee HS; Kwon HJ
Exp Mol Med; 2017 Nov; 49(11):e391. PubMed ID: 29147009
[TBL] [Abstract][Full Text] [Related]
60. Clinical significance of HSP27 expression in colorectal cancer.
Yu Z; Zhi J; Peng X; Zhong X; Xu A
Mol Med Rep; 2010; 3(6):953-8. PubMed ID: 21472339
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
